Category: CNS/Neurology
CNS/Neurology market research reports by IMARC Services Pvt. Ltd.
-
In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033
The global in-vivo CRO market size reached USD 5.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.76% during 2025-2033. The growing prevalence of chronic diseases worldwide and the increasing R&D expenditure by ... Read More
-
Single Cell Multiomics Market Report by Type (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics), Product Type (Consumables, Instruments, Software), Technique (Single-Cell Isolation and Dispensing, Single-Cell Analysis), Application (Oncology, Cell Biology, Neurology, and Others), End User (Academic Institutes, Contract Research Organizations, Pharmaceutical and Biotech Companies), and Region 2025-2033
The global single cell multiomics market size reached USD 4.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 16.6 Billion by 2033, exhibiting a growth rate (CAGR) of 14.6% during 2025-2033. Single cell multiomics refers to the analysis of multiple types of molecules fr ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market Report by ALS Type (Sporadic ALS, Familial ALS), Drug Type (Marketed Drugs, Emerging Drugs), Diagnosis Type (Electromyogram, MRI, Blood and Urine Tests, Spinal Tap, Muscle Biopsy), Treatment (Medication, Stem Cell Therapy, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2025-2033
The global amyotrophic lateral sclerosis treatment market size reached USD 787.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,134.5 Million by 2033, exhibiting a growth rate (CAGR) of 4.15% during 2025-2033. Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a ... Read More
-
Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2025-2033
The global clinical nutrition market size reached USD 55.8 Billion in 2024. Looking forward, the market is expected to reach USD 104.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033. There are various factors that are driving the market, which include increasing prevalence ... Read More
-
Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2025-2033
The global biomarkers market size reached USD 89.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 249.4 Billion by 2033, exhibiting a growth rate (CAGR) of 10.8% during 2025-2033. The rising prevalence of chronic diseases, ongoing developments in biotechnology and geno ... Read More
-
RNA Interference (RNAi) Drug Delivery Market Report by Application (Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others), Technology (Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, Aptamer Drug Delivery), and Region 2025-2033
The global RNA interference (RNAi) drug delivery market size reached USD 99.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 466.1 Billion by 2033, exhibiting a growth rate (CAGR) of 17.75% during 2025-2033. Ribonucleic acid interference (RNAi) drug delivery refers to ... Read More
-
Deep Brain Stimulation Market Report by Stimulation Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Application (Parkinson's Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), and Others), End-User (Hospitals, Ambulatory Surgical Centers, Neurological Centers, and Others), and Region 2025-2033
The global deep brain stimulation market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2033, exhibiting a growth rate (CAGR) of 7.91% during 2025-2033. The rising occurrence of various motor and neurological disorders among the mass ... Read More
-
Pain Management Drugs Market Report by Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, and Others), Indication (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine Pain, Obstetrical Pain, Fibromyalgia Pain, Burn Pain, Dental/Facial Pain, Pediatric Pain, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
The global pain management drugs market size reached USD 71.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 88.7 Billion by 2033, exhibiting a growth rate (CAGR) of 2.32% during 2025-2033. The market is experiencing robust growth driven by the increasing prevalence of ... Read More
-
Regenerative Medicine Market Report by Type (Stem Cell Therapy, Biomaterial, Tissue Engineering, and Others), Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System, and Others), End User (Hospitals, Specialty Clinics, and Others), and Region 2025-2033
Regenerative Medicine Market Report by Type (Stem Cell Therapy, Biomaterial, Tissue Engineering, and Others), Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System, and Others), End User (Hospitals, Specialty Clinics, and Others), and Regio ... Read More
-
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report by Type (Autologous Stem Cells, Autologous Non-Stem Cells), Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, Research Facilities), and Region 2025-2033
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report by Type (Autologous Stem Cells, Autologous Non-Stem Cells), Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, Research Faci ... Read More
-
Precision Medicine Market Report by Product (Consumables, Instruments, Services), Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, and Others), Application (Oncology, Central Nervous System (CNS), Immunology, Respiratory Medicine, Infections, and Others), End User (Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, and Others), and Region 2024-2032
Precision Medicine Market Report by Product (Consumables, Instruments, Services), Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, and Others), Application (Oncology, Central Nervous System (CNS), Immunology, Respiratory Medicine, Infections, an ... Read More
-
Nuclear Medicine Equipment Market Report by Product (Single-Photon Emission Computed Tomography, Positron Emission Tomography, Planar Scintigraphy), Application (Neurology, Oncology, Cardiology, and Others), End User (Hospitals, Imaging Centers, Academic and Research Institutes, and Others), and Region 2024-2032
Nuclear Medicine Equipment Market Report by Product (Single-Photon Emission Computed Tomography, Positron Emission Tomography, Planar Scintigraphy), Application (Neurology, Oncology, Cardiology, and Others), End User (Hospitals, Imaging Centers, Academic and Research Institutes, and Others), and Reg ... Read More
-
Brain Health Supplements Market Report by Product (Natural Molecules, Herbal Extract, Vitamins and Minerals), Form (Tablets and Capsules, Powder, and Others), Distribution Channel (Supermarkets and Hypermarkets, Drug Stores, Online Stores, and Others), Application (Memory Enhancement, Attention and Focus, Depression and Mood, Sleep and Recovery, Anti-aging and Longevity, and Others), and Region 2024-2032
Brain Health Supplements Market Report by Product (Natural Molecules, Herbal Extract, Vitamins and Minerals), Form (Tablets and Capsules, Powder, and Others), Distribution Channel (Supermarkets and Hypermarkets, Drug Stores, Online Stores, and Others), Application (Memory Enhancement, Attention and ... Read More
-
Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032
Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Di ... Read More
-
Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032
Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinica ... Read More
-
Magnetic Resonance Imaging (MRI) Systems Market Report by Architecture (Closed System, Open System), Field Strength (Low Field Strength, Mid Field Strength, High Field Strength), Application (Oncology, Neurology, Cardiology, Gastroenterology, Musculoskeletal, and Others), End Use (Hospitals, Imaging Centers, Ambulatory Surgical Centers, and Others), Technology (MR Angiogram, MR Venogram, Functional MRI, MR Spectroscopy, and Others), and Region 2024-2032
Magnetic Resonance Imaging (MRI) Systems Market Report by Architecture (Closed System, Open System), Field Strength (Low Field Strength, Mid Field Strength, High Field Strength), Application (Oncology, Neurology, Cardiology, Gastroenterology, Musculoskeletal, and Others), End Use (Hospitals, Imaging ... Read More
-
Schizophrenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
Schizophrenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major schizophrenia markets reached a value of US$ 9,480.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 15,236.9 Million by 2034, exhibiting a growth rate ... Read More
-
Subdural Haematoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
Subdural Haematoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major subdural haematoma markets are expected to exhibit a CAGR of 3.61% during 2024-2034. The subdural haematoma market has been comprehensively analyzed in IMARC’s new report ... Read More
-
Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major encephalitis markets reached a value of US$ 15.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.4 Billion by 2034, exhibiting a growth rate (CAGR) o ... Read More
-
Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2024-2032
Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2024-2032 ... Read More
-
North America Analgesics Market Report by Type (Prescription Analgesics, OTC Analgesics), Drug Class (Opioids, NSAID, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine, Obstetrical Pain, Fibromyalgia, Pain due to Burns, Dental/Facial Pain, Pediatric Pain, and Others), Application (Internal Analgesics, External Analgesics), and Country 2024-2032
North America Analgesics Market Report by Type (Prescription Analgesics, OTC Analgesics), Drug Class (Opioids, NSAID, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migra ... Read More
-
Mental Health Market Report by Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression and Anxiety, Post-traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, and Others), Service (Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment Services, Inpatient Hospital Treatment Services, and Others), Age Group (Pediatric, Adult, Geriatric), and Region 2024-2032
Mental Health Market Report by Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression and Anxiety, Post-traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, and Others), Service (Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment S ... Read More
-
Analgesics Market Report by Type (Prescription, Over-The-Counter (OTC)), Drug Class (Opioids, NSAIDs, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain due to Burns, Dental/Facial, Pediatric, and Others), Application (Internal, External), and Region 2024-2032
Analgesics Market Report by Type (Prescription, Over-The-Counter (OTC)), Drug Class (Opioids, NSAIDs, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain ... Read More
-
Brain Computer Interface Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Brain Computer Interface Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 The global brain computer interface market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate ... Read More
-
Neurological Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Neurological Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 The global neurological biomarkers market size reached US$ 7.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.4 Billion by 2028, exhibiting a growth rate ... Read More